Dai­ichi, Al­teogen to work on sub­cu­ta­neous En­her­tu; Roche ends Nykode deal

Plus, news about Disc Med­i­cine, AlloVir, Kalaris, Tra­vere Ther­a­peu­tics and Treve­na:

Dai­ichi Sankyo, Al­teogen to de­vel­op sub­cu­ta­neous ver­sion of En­her­tu: Dai­ichi will pay $20 mil­lion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER